Search for: "Sanofi"
Results 61 - 80
of 1,195
Sort by Relevance
|
Sort by Date
19 Oct 2023, 6:22 am
The courts below rejected Sanofi’s request for extending the time limits, because most of the annexes were already available to Sanofi. [read post]
18 Oct 2023, 4:58 pm
Sanofi, the Supreme Court stated that “the specification much enable the full scope of the invention as defined by its claims,” allowing for “a reasonable amount of experimentation. [read post]
11 Oct 2023, 8:17 am
The post Sanofi Adds Biologics to Its AI Ambitions, Striking Up R&D Alliance With BioMap appeared first on Above the Law. [read post]
9 Oct 2023, 10:45 pm
With the central case law and regulatory updates, this event focuses on the European market and those working within life science IP.As the agenda also indicates, the following promise to be the highlights of this year’s edition:Form a holistic and practical UPC litigation strategy with a cross-industry case law review, a mock trial alongside leading judges and litigators and a pharma and biotech UPC strategy panel.Update one’s own pharma and biotech patent litigation strategy with the… [read post]
4 Oct 2023, 5:27 pm
Sanofi, 143 S. [read post]
4 Oct 2023, 12:19 pm
Sanofi decision for both biotech and “regular” tech. [read post]
3 Oct 2023, 4:15 am
Sanofi on May 18, 2023, nearly nine years after its decision in Alice Corp. v. [read post]
3 Oct 2023, 4:15 am
Sanofi on May 18, 2023, nearly nine years after its decision in Alice Corp. v. [read post]
2 Oct 2023, 9:32 pm
By Kevin E. [read post]
29 Sep 2023, 2:52 am
Amgen v Sanofi, IPKat). [read post]
28 Sep 2023, 6:22 am
Sanofi</em> appeared first on Gibbons Law Alert. [read post]
28 Sep 2023, 6:22 am
Sanofi</em> appeared first on Gibbons Law Alert. [read post]
28 Sep 2023, 6:22 am
Sanofi</em> appeared first on Gibbons Law Alert. [read post]
20 Sep 2023, 9:39 am
Sanofi, 598 U.S. 594 (2023). [read post]
10 Sep 2023, 9:15 am
Sanofi, 143 S. [read post]
10 Sep 2023, 9:15 am
Sanofi, 143 S. [read post]
26 Aug 2023, 9:16 am
Settlement As was pointed out in an article of EIP Amar, ‘many of the parties involved in (…) initial infringement actions are pairings familiar from litigation already being fought in UK, Germany or US, such as Edwards Life Sciences against Meril, Ocado against Autostore and Amgen against Sanofi / Regeneron’. [read post]
7 Aug 2023, 6:01 am
., and Sanofi-Aventis U.S. [read post]
2 Aug 2023, 11:28 am
Sanofi. [read post]
2 Aug 2023, 11:05 am
Sanofi further argued that the Board improperly shifted the burden of persuasion from Mylan to prove that the challenged claims were unpatentable to Sanofi to defend the claims of the ’614 patent as patentable. [read post]
